Acta Orthopaedica et Traumatologica Turcica
Research Article
One step treatment of talus osteochondral lesions with microfracture and cell free hyaluronic acid based scaffold combination

One step treatment of talus osteochondral lesions with microfracture and cell free hyaluronic acid based scaffold combination

1.

Nisantasi Ortopedi Merkezi, Ayak-Ayak bilegi cerrahisi klinigi, Istanbul, Turkey

2.

Bitlis Central State Hospital, Department of Orthopaedics and Traumatology, Bitlis, Turkey

AOTT 2019; 53: 372-375
DOI: 10.1016/j.aott.2019.04.002
Read: 296 Downloads: 153 Published: 12 December 2019

Objective: The aim of this study was to assess the effectiveness of microfracture and cell free hyaluronic acid (HA) based scaffold combination in the treatment of talus osteochondral defects (OCD).

Methods: This study retrospectively evaluated the clinical results of the 20 patients (14 males and 6 females, mean age at the time of surgery: 32.9 years (range: 16e52 years)) who were treated with MFx and cell-free HA-based scaffold combination for talus OCD smaller than 1.5 cm2 and deeper than 7 mm. Results were evaluated with AOFAS and VAS scores. Also, patients' satisfaction was questioned.

Results: Patients were evaluated after an average follow-up of 20.3 months. Intraoperative measurements showed that mean depth of the lesions were 10.4 ± 1.9 mm after debridement. The mean preoperative AOFAS score was 57.45 ± 9.37, which increased to 92.45 ± 8.4 postoperatively (p < 0.05). VAS score was improved from 7.05 ± 2.45 to 1.65 ± 2.20 postoperatively (p < 0.05).

Conclusion: MFx and cell-free HA-based scaffold combination appear to be a safe and efficient technique that provide good clinical outcomes for lesions deeper than 7 mm.


Level of evidence: Level IV, Therapeutic Study.

Files
ISSN 1017-995X EISSN 2589-1294